Chronic dyspnea, or persistent shortness of breath, is a common symptom in patients with respiratory, cardiovascular, or neuromuscular disorders. It can significantly impair daily activities, reduce exercise tolerance, and diminish quality of life. Causes range from chronic obstructive pulmonary disease, interstitial lung disease, and pulmonary hypertension to heart failure, anemia, and obesity. Assessment involves a comprehensive clinical evaluation, including pulmonary function tests, imaging, cardiopulmonary exercise testing, and evaluation of comorbidities to determine the underlying contributors and severity of breathlessness. Tailoring interventions based on these findings is crucial for achieving meaningful chronic dyspnea relief.
Management strategies combine pharmacologic, non-pharmacologic, and supportive measures. Medications such as bronchodilators, corticosteroids, and diuretics are used depending on the underlying pathology to improve airflow, reduce inflammation, and manage fluid overload. Non-drug approaches, including pulmonary rehabilitation, structured aerobic exercise, breathing retraining, and energy-conservation techniques, enhance respiratory efficiency and reduce the perception of breathlessness. Supplemental oxygen may be prescribed for patients with chronic hypoxemia, while anxiety and fatigue associated with dyspnea are addressed through cognitive behavioral therapy or relaxation strategies. Patient education on symptom recognition, pacing activities, and adherence to treatment plans is essential. Multidisciplinary care involving pulmonologists, cardiologists, physiotherapists, and respiratory therapists ensures a holistic approach. Implementing comprehensive strategies for chronic dyspnea relief improves functional capacity, supports independence, and enhances overall well-being for patients living with long-term respiratory challenges.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation